| Symbol | RLYB |
|---|---|
| Name | RALLYBIO CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 234 CHURCH STREET, NEW HAVEN, CT 06510 |
| Telephone | 203- 859-3820 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001739410 |
| Description | None |
New Form SCHEDULE 13G/A - Rallybio Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-097296 <b>Size:</b> 11 KB
Read moreNew Form SCHEDULE 13G/A - Rallybio Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003694 <b>Size:</b> 9 KB
Read moreNew Form SCHEDULE 13G/A - Rallybio Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003435 <b>Size:</b> 13 KB
Read moreNew Form SCHEDULE 13G - Rallybio Corp <b>Filed:</b> 2026-06-05 <b>AccNo:</b> 0001104659-26-071013 <b>Size:</b> 14 KB
Read moreRallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
Read moreRLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders
Read moreRallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
Read moreADAR1 Capital Management, LLC 🟢 acquired 16.2K shares of Rallybio Corp (RLYB) at $13.98 Transaction Date: May 18, 2026 | Filing ID: 064729
Read moreADAR1 Capital Management, LLC 🟢 acquired 79.6K shares of Rallybio Corp (RLYB) at $14.00 ($1.1M) Transaction Date: May 13, 2026 | Filing ID: 062883
Read more